Fidelity Investments’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-4,802,713
| Closed | -$93.4M | – | 2796 |
|
|
2018
Q1 | $93.4M | Buy |
4,802,713
+4,577,913
| +2,036% | +$89.8M | 0.01% | 1013 |
|
|
2017
Q4 | $3.74M | Sell |
224,800
-47,700
| -18% | -$874K | ﹤0.01% | 2230 |
|
|
2017
Q3 | $5.53M | Sell |
272,500
-123,600
| -31% | -$2.36M | ﹤0.01% | 2130 |
|
|
2017
Q2 | $6.38M | Sell |
396,100
-102,400
| -21% | -$1.51M | ﹤0.01% | 2100 |
|
|
2017
Q1 | $6.31M | Buy |
498,500
+95,432
| +24% | +$1.15M | ﹤0.01% | 2119 |
|
|
2016
Q4 | $5.34M | Sell |
403,068
-78,682
| -16% | -$1.35M | ﹤0.01% | 2164 |
|
|
2016
Q3 | $11.4M | Buy |
481,750
+245,624
| +104% | +$6.6M | ﹤0.01% | 1932 |
|
|
2016
Q2 | $6.8M | Sell |
236,126
-70,454
| -23% | -$2.3M | ﹤0.01% | 2107 |
|
|
2016
Q1 | $9.82M | Buy |
306,580
+91,300
| +42% | +$3.21M | ﹤0.01% | 1974 |
|
|
2015
Q4 | $9.21M | Sell |
215,280
-38,700
| -15% | -$1.55M | ﹤0.01% | 2021 |
|
|
2015
Q3 | $8.94M | Sell |
253,980
-55,500
| -18% | -$2.5M | ﹤0.01% | 1992 |
|
|
2015
Q2 | $14.2M | Sell |
309,480
-1,564,803
| -83% | -$74.3M | ﹤0.01% | 1879 |
|
|
2015
Q1 | $87.8M | Sell |
1,874,283
-1,145,100
| -38% | -$45.6M | 0.01% | 1080 |
|
|
2014
Q4 | $95.7M | Buy |
3,019,383
+722,200
| +31% | +$21.1M | 0.01% | 1028 |
|
|
2014
Q3 | $54.5M | Sell |
2,297,183
-1,479,349
| -39% | -$37.9M | 0.01% | 1266 |
|
|
2014
Q2 | $113M | Sell |
3,776,532
-447,955
| -11% | -$12.1M | 0.02% | 936 |
|
|
2014
Q1 | $112M | Sell |
4,224,487
-315,934
| -7% | -$7.9M | 0.02% | 928 |
|
|
2013
Q4 | $114M | Buy |
4,540,421
+182,845
| +4% | +$4.08M | 0.02% | 897 |
|
|
2013
Q3 | $89.4M | Sell |
4,357,576
-572,098
| -12% | -$11.8M | 0.01% | 1008 |
|
|
2013
Q2 | $98.3M | Buy |
+4,929,674
| New | +$87.5M | 0.02% | 924 |
|
Fidelity Investments's IPXL Position: Q2 2018 in Review
Fidelity Investments sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 4,802,713 shares — an estimated $93.4M sold.
Fidelity Investments first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $114M in Q4 2013. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Fidelity Investments reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Fidelity Investments sold 4,802,713 Impax Laboratories, Inc. shares in Q2 2018, an estimated $93.4M.
- Fidelity Investments first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Fidelity Investments's Impax Laboratories, Inc. position peaked at $114M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Fidelity Investments's 13F filing for Q2 2018, filed 10 Aug 2018.